Cytokeratin 18 anticorps (C-Term)
Aperçu rapide pour Cytokeratin 18 anticorps (C-Term) (ABIN870569)
Antigène
Voir toutes Cytokeratin 18 (KRT18) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 412-429, C-Term
-
Fonction
- Anti-Cytokeratin 18
-
Specificité
- Cytokeratin 18
-
Immunogène
- Peptide derived from C-terminal region of human cytokeratin 18. Antibody recognizes the epitope between Arg412 - Arg429.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- 1:100 - 300
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- 20 mM Tris-HCI, pH 8.0, Stabilizer: 20 mg/mL BSA, Preservative: 0.05 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- +2 °C to +8 °C
-
-
- Cytokeratin 18 (KRT18) (Keratin 18 (KRT18))
-
Autre désignation
- Cytokeratin 18
-
Sujet
- Immunohistochemistry of Cytokeratin 18 is used for diagnostics of cancer in glandular epithelia. Discrepancies in expression are detected in several types of carcinomas: colon, respiratory, urogenital, endocrine and exocrine tissues.
-
UniProt
- P05783
-
Pathways
- Apoptose, Caspase Cascade in Apoptosis
Antigène
-